Cryopyrin-Associated Periodic Syndromes

Immunology·MeSH: Cryopyrin-Associated Periodic Syndromes

4 drugs in development·4 companies·0 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
arcalyst	X4 Pharmaceuticals, Inc (XFOR)
ARCALYST	Kiniksa Pharmaceuticals International, plc (KNSA)

Phase 1(2)

Drug	Company
JTE-162	Akero Therapeutics, Inc. (AKRO)
JTE-162	Keros Therapeutics, Inc. (KROS)

Full trial data, competitive analysis, and AI-powered pipeline tracking.